Everence Capital Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Everence Capital Management’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-8,070	Closed	-$344K	–	772
2021 Q2	$344K	Hold	8,070	–	–	0.03%	522
2021 Q1	$309K	Hold	8,070	–	–	0.03%	545
2020 Q4	$353K	Hold	8,070	–	–	0.03%	454
2020 Q3	$318K	Hold	8,070	–	–	0.04%	444
2020 Q2	$312K	Hold	8,070	–	–	0.04%	444
2020 Q1	$284K	Hold	8,070	–	–	0.04%	396
2019 Q4	$392K	Hold	8,070	–	–	0.06%	378
2019 Q3	$383K	Hold	8,070	–	–	0.06%	345
2019 Q2	$346K	Hold	8,070	–	–	0.06%	382
2019 Q1	$312K	Buy	+8,070	New	+$274K	0.05%	396

Other funds holding CSII

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Everence Capital Management's CSII Position: Q3 2021 in Review

Everence Capital Management sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2021, closing a stake of 8,070 shares — an estimated $344K sold.

Everence Capital Management first reported a position in CSII in Q1 2019 and held it in 10 quarters. The position peaked at $392K in Q4 2019. 171 funds tracked by Wall St. Rank hold CSII as of Q3 2021.

Everence Capital Management reported no remaining Cardiovascular Systems, Inc. position as of Q3 2021 after selling out during the quarter.
Everence Capital Management sold 8,070 Cardiovascular Systems, Inc. shares in Q3 2021, an estimated $344K.
Everence Capital Management first reported a position in Cardiovascular Systems, Inc. in Q1 2019 and held it in 10 quarters.
Everence Capital Management's Cardiovascular Systems, Inc. position peaked at $392K in Q4 2019.
171 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2021.

Based on Everence Capital Management's 13F filing for Q3 2021, filed 21 Oct 2021.